메뉴 건너뛰기




Volumn 172, Issue , 2016, Pages 127-135

Cost-effectiveness/cost-benefit analysis of newborn screening for severe combined immune deficiency in Washington State

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE DEFICIENCY; CONFERENCE PAPER; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DECISION TREE; ECONOMIC ASPECT; HEALTH CARE COST; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SCREENING; PREVALENCE; PRIORITY JOURNAL; SCREENING TEST; SEVERE COMBINED IMMUNODEFICIENCY; SURVIVAL RATE; UNITED STATES; DECISION SUPPORT SYSTEM; ECONOMICS; SENSITIVITY AND SPECIFICITY; THEORETICAL MODEL; WASHINGTON;

EID: 84971454085     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2016.01.029     Document Type: Conference Paper
Times cited : (47)

References (59)
  • 1
    • 84855317098 scopus 로고    scopus 로고
    • The case for newborn screening for severe combined immunodeficiency and related disorders
    • J.M. Puck The case for newborn screening for severe combined immunodeficiency and related disorders Ann N Y Acad Sci 1246 2011 108 117
    • (2011) Ann N y Acad Sci , vol.1246 , pp. 108-117
    • Puck, J.M.1
  • 2
    • 34948870078 scopus 로고    scopus 로고
    • Population-based newborn screening for severe combined immunodeficiency: Steps toward implementation
    • J.M. Puck Population-based newborn screening for severe combined immunodeficiency: steps toward implementation J Allergy Clin Immunol 120 2007 760 768
    • (2007) J Allergy Clin Immunol , vol.120 , pp. 760-768
    • Puck, J.M.1
  • 3
    • 77955507132 scopus 로고    scopus 로고
    • Why newborn screening for severe combined immunodeficiency is essential: A case report
    • M.M. Adeli, and R.H. Buckley Why newborn screening for severe combined immunodeficiency is essential: a case report Pediatrics 126 2010 e465 e469
    • (2010) Pediatrics , vol.126 , pp. e465-e469
    • Adeli, M.M.1    Buckley, R.H.2
  • 4
    • 79953082197 scopus 로고    scopus 로고
    • Neonatal diagnosis of severe combined immunodeficiency leads to significantly improved survival outcome: The case for newborn screening
    • L. Brown, J. Xu-Bayford, Z. Allwood, M. Slatter, A. Cant, E.G. Davies, and et al. Neonatal diagnosis of severe combined immunodeficiency leads to significantly improved survival outcome: the case for newborn screening Blood 117 2011 3243 3246
    • (2011) Blood , vol.117 , pp. 3243-3246
    • Brown, L.1    Xu-Bayford, J.2    Allwood, Z.3    Slatter, M.4    Cant, A.5    Davies, E.G.6
  • 5
    • 78651362824 scopus 로고    scopus 로고
    • Early vs. Delayed diagnosis of severe combined immunodeficiency: A family perspective survey
    • A. Chan, C. Scalchunes, M. Boyle, and J.M. Puck Early vs. delayed diagnosis of severe combined immunodeficiency: a family perspective survey Clin Immunol 138 2011 3 8
    • (2011) Clin Immunol , vol.138 , pp. 3-8
    • Chan, A.1    Scalchunes, C.2    Boyle, M.3    Puck, J.M.4
  • 6
    • 84927697326 scopus 로고    scopus 로고
    • Stem cell transplantation for primary immunodeficiency diseases: The North American experience
    • S.Y. Pai, and M.J. Cowan Stem cell transplantation for primary immunodeficiency diseases: the North American experience Curr Opin Allergy Clin Immunol 14 2014 521 526
    • (2014) Curr Opin Allergy Clin Immunol , vol.14 , pp. 521-526
    • Pai, S.Y.1    Cowan, M.J.2
  • 7
    • 80955145637 scopus 로고    scopus 로고
    • A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID)
    • K. Chan, J. Davis, S.Y. Pai, F.A. Bonilla, J.M. Puck, and M. Apkon A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID) Mol Genet Metab 104 2011 383 389
    • (2011) Mol Genet Metab , vol.104 , pp. 383-389
    • Chan, K.1    Davis, J.2    Pai, S.Y.3    Bonilla, F.A.4    Puck, J.M.5    Apkon, M.6
  • 8
    • 0036464666 scopus 로고    scopus 로고
    • Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival
    • L.A. Myers, D.D. Patel, J.M. Puck, and R.H. Buckley Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival Blood 99 2002 872 878
    • (2002) Blood , vol.99 , pp. 872-878
    • Myers, L.A.1    Patel, D.D.2    Puck, J.M.3    Buckley, R.H.4
  • 9
    • 0028291342 scopus 로고
    • Early diagnosis of severe combined immunodeficiency syndrome
    • R.A. Hague, S. Rassam, G. Morgan, and A.J. Cant Early diagnosis of severe combined immunodeficiency syndrome Arch Dis Child 70 1994 260 263
    • (1994) Arch Dis Child , vol.70 , pp. 260-263
    • Hague, R.A.1    Rassam, S.2    Morgan, G.3    Cant, A.J.4
  • 10
    • 84857757608 scopus 로고    scopus 로고
    • The long quest for neonatal screening for severe combined immunodeficiency
    • quiz 5-6
    • R.H. Buckley The long quest for neonatal screening for severe combined immunodeficiency J Allergy Clin Immunol 129 2012 597 604 quiz 5-6
    • (2012) J Allergy Clin Immunol , vol.129 , pp. 597-604
    • Buckley, R.H.1
  • 12
    • 79952698207 scopus 로고    scopus 로고
    • Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: Long-term outcomes
    • R.H. Buckley Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: long-term outcomes Immunol Res 49 2011 25 43
    • (2011) Immunol Res , vol.49 , pp. 25-43
    • Buckley, R.H.1
  • 13
    • 84906543118 scopus 로고    scopus 로고
    • Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States
    • A. Kwan, R.S. Abraham, R. Currier, A. Brower, K. Andruszewski, J.K. Abbott, and et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States JAMA 312 2014 729 738
    • (2014) JAMA , vol.312 , pp. 729-738
    • Kwan, A.1    Abraham, R.S.2    Currier, R.3    Brower, A.4    Andruszewski, K.5    Abbott, J.K.6
  • 14
    • 77954877133 scopus 로고    scopus 로고
    • Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID)
    • C. Booth, and H.B. Gaspar Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID) Biologics 3 2009 349 358
    • (2009) Biologics , vol.3 , pp. 349-358
    • Booth, C.1    Gaspar, H.B.2
  • 15
    • 84867745449 scopus 로고    scopus 로고
    • Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency
    • quiz 26
    • A. Hassan, C. Booth, A. Brightwell, Z. Allwood, P. Veys, K. Rao, and et al. Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency Blood 120 2012 3615 3624 quiz 26
    • (2012) Blood , vol.120 , pp. 3615-3624
    • Hassan, A.1    Booth, C.2    Brightwell, A.3    Allwood, Z.4    Veys, P.5    Rao, K.6
  • 16
    • 84858308338 scopus 로고    scopus 로고
    • Gene therapy for severe combined immunodeficiency due to adenosine deaminase deficiency
    • C.A. Montiel-Equihua, A.J. Thrasher, and H.B. Gaspar Gene therapy for severe combined immunodeficiency due to adenosine deaminase deficiency Curr Gene Ther 12 2012 57 65
    • (2012) Curr Gene Ther , vol.12 , pp. 57-65
    • Montiel-Equihua, C.A.1    Thrasher, A.J.2    Gaspar, H.B.3
  • 17
    • 26044474889 scopus 로고    scopus 로고
    • Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID)
    • B. Chan, D. Wara, J. Bastian, M.S. Hershfield, J. Bohnsack, C.G. Azen, and et al. Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID) Clin Immunol 117 2005 133 143
    • (2005) Clin Immunol , vol.117 , pp. 133-143
    • Chan, B.1    Wara, D.2    Bastian, J.3    Hershfield, M.S.4    Bohnsack, J.5    Azen, C.G.6
  • 18
    • 84868589740 scopus 로고    scopus 로고
    • Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: Clinical comparison of retroviral vectors and treatment plans
    • F. Candotti, K.L. Shaw, L. Muul, D. Carbonaro, R. Sokolic, C. Choi, and et al. Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans Blood 120 2012 3635 3646
    • (2012) Blood , vol.120 , pp. 3635-3646
    • Candotti, F.1    Shaw, K.L.2    Muul, L.3    Carbonaro, D.4    Sokolic, R.5    Choi, C.6
  • 19
    • 77951778042 scopus 로고    scopus 로고
    • Systematic evidence review of newborn screening and treatment of severe combined immunodeficiency
    • E.A. Lipstein, S. Vorono, M.F. Browning, N.S. Green, A.R. Kemper, A.A. Knapp, and et al. Systematic evidence review of newborn screening and treatment of severe combined immunodeficiency Pediatrics 125 2010 e1226 e1235
    • (2010) Pediatrics , vol.125 , pp. e1226-e1235
    • Lipstein, E.A.1    Vorono, S.2    Browning, M.F.3    Green, N.S.4    Kemper, A.R.5    Knapp, A.A.6
  • 20
    • 84901830934 scopus 로고    scopus 로고
    • Reflections on 50 years of newborn screening
    • C.A. Boyle, J.A. Bocchini Jr., and J. Kelly Reflections on 50 years of newborn screening Pediatrics 133 2014 961 963
    • (2014) Pediatrics , vol.133 , pp. 961-963
    • Boyle, C.A.1    Bocchini, J.A.2    Kelly, J.3
  • 22
    • 84862249006 scopus 로고    scopus 로고
    • Newborn screening for severe combined immunodeficiency; The Wisconsin experience (2008-2011)
    • J.W. Verbsky, M.W. Baker, W.J. Grossman, M. Hintermeyer, T. Dasu, B. Bonacci, and et al. Newborn screening for severe combined immunodeficiency; the Wisconsin experience (2008-2011) J Clin Immunol 32 2012 82 88
    • (2012) J Clin Immunol , vol.32 , pp. 82-88
    • Verbsky, J.W.1    Baker, M.W.2    Grossman, W.J.3    Hintermeyer, M.4    Dasu, T.5    Bonacci, B.6
  • 24
    • 79952199261 scopus 로고    scopus 로고
    • Guidelines for implementation of population-based newborn screening for severe combined immunodeficiency
    • A.M. Comeau, J.E. Hale, S.Y. Pai, F.A. Bonilla, L.D. Notarangelo, M.S. Pasternack, and et al. Guidelines for implementation of population-based newborn screening for severe combined immunodeficiency J Inherit Metab Dis 33 2010 S273 S281
    • (2010) J Inherit Metab Dis , vol.33 , pp. S273-S281
    • Comeau, A.M.1    Hale, J.E.2    Pai, S.Y.3    Bonilla, F.A.4    Notarangelo, L.D.5    Pasternack, M.S.6
  • 25
    • 84922640470 scopus 로고    scopus 로고
    • NewSTEPS; Association of Public Health Laboratories Accessed October 4, 2015
    • NewSTEPS; Association of Public Health Laboratories. Severe Combined Immunodeficiency (SCID). https://www.newsteps.org/scid. Accessed October 4, 2015.
    • Severe Combined Immunodeficiency (SCID)
  • 27
    • 84874296976 scopus 로고    scopus 로고
    • Revised Code of Washington (RCW) 34.05.328 Section (1)(b). Accessed June 24, 2015
    • Washington State Legislature. Revised Code of Washington (RCW) 34.05.328 Section (1)(b). http://apps.leg.wa.gov/rcw/default.aspx?cite=34.05&full=true. Accessed June 24, 2015.
    • Washington State Legislature
  • 28
    • 84882791221 scopus 로고    scopus 로고
    • Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: Results of the first 2 years
    • A. Kwan, J.A. Church, M.J. Cowan, R. Agarwal, N. Kapoor, D.B. Kohn, and et al. Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2 years J Allergy Clin Immunol 132 2013 140 150
    • (2013) J Allergy Clin Immunol , vol.132 , pp. 140-150
    • Kwan, A.1    Church, J.A.2    Cowan, M.J.3    Agarwal, R.4    Kapoor, N.5    Kohn, D.B.6
  • 29
    • 27744515099 scopus 로고    scopus 로고
    • Potential costs and benefits of newborn screening for severe combined immunodeficiency
    • S.A. McGhee, E.R. Stiehm, and E.R. McCabe Potential costs and benefits of newborn screening for severe combined immunodeficiency J Pediatr 147 2005 603 608
    • (2005) J Pediatr , vol.147 , pp. 603-608
    • McGhee, S.A.1    Stiehm, E.R.2    McCabe, E.R.3
  • 30
    • 84894660342 scopus 로고    scopus 로고
    • An analysis and decision tool to measure cost benefit of newborn screening for severe combined immunodeficiency (SCID) and related T-cell lymphopenia
    • V. Modell, M. Knaus, and F. Modell An analysis and decision tool to measure cost benefit of newborn screening for severe combined immunodeficiency (SCID) and related T-cell lymphopenia Immunol Res 60 2014 145 152
    • (2014) Immunol Res , vol.60 , pp. 145-152
    • Modell, V.1    Knaus, M.2    Modell, F.3
  • 32
    • 84973434376 scopus 로고    scopus 로고
    • A global economic evaluation simulation model of cost-savings in newborn screening for severe combined immunodeficiency
    • Birmingham, United Kingdom
    • Chan K. A global economic evaluation simulation model of cost-savings In newborn screening for severe combined immunodeficiency. 9th International Society for Neonatal Screening European Regional Meeting 2014. Birmingham, United Kingdom; 2014.
    • (2014) 9th International Society for Neonatal Screening European Regional Meeting 2014
    • Chan, K.1
  • 33
    • 84902524090 scopus 로고    scopus 로고
    • Skills of the trade: Valuing health risk reductions in benefit-cost analysis
    • L.A. Robinson, and J.K. Hammitt Skills of the trade: valuing health risk reductions in benefit-cost analysis J Benefit Cost Anal 4 2013 107 130
    • (2013) J Benefit Cost Anal , vol.4 , pp. 107-130
    • Robinson, L.A.1    Hammitt, J.K.2
  • 34
    • 84978816634 scopus 로고    scopus 로고
    • The role of publication selection bias in estimates of the value of a statistical life
    • W.K. Viscusi The role of publication selection bias in estimates of the value of a statistical life Am J Health Econ 1 2015 27 52
    • (2015) Am J Health Econ , vol.1 , pp. 27-52
    • Viscusi, W.K.1
  • 35
    • 84973434790 scopus 로고    scopus 로고
    • Washington State Department of Health Accessed December 7, 2014
    • Washington State Department of Health. Vital Statistics Data for Birth Tables in 2013. http://www.doh.wa.gov/DataandStatisticalReports/VitalStatisticsData/BirthData/BirthTablesbyYear. Accessed December 7, 2014.
    • Vital Statistics Data for Birth Tables in 2013
  • 36
    • 84908123060 scopus 로고    scopus 로고
    • Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency
    • C.C. Dvorak, A. Hassan, M.A. Slatter, M. Honig, A.C. Lankester, R.H. Buckley, and et al. Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency J Allergy Clin Immunol 134 2014 935 943.e15
    • (2014) J Allergy Clin Immunol , vol.134 , pp. 935-943e15
    • Dvorak, C.C.1    Hassan, A.2    Slatter, M.A.3    Honig, M.4    Lankester, A.C.5    Buckley, R.H.6
  • 39
    • 84898037210 scopus 로고    scopus 로고
    • United States life tables, 2009
    • E. Arias United States life tables, 2009 Natl Vital Stat Rep 62 2014 1 63
    • (2014) Natl Vital Stat Rep , vol.62 , pp. 1-63
    • Arias, E.1
  • 40
    • 46949100710 scopus 로고    scopus 로고
    • Assessing cost-effectiveness in healthcare: History of the $50 000 per QALY threshold
    • S.D. Grosse Assessing cost-effectiveness in healthcare: history of the $50 000 per QALY threshold Expert Rev Pharmacoecon Outcomes Res 8 2008 165 178
    • (2008) Expert Rev Pharmacoecon Outcomes Res , vol.8 , pp. 165-178
    • Grosse, S.D.1
  • 41
    • 84907360483 scopus 로고    scopus 로고
    • Updating cost-effectiveness - The curious resilience of the $50 000-per-QALY threshold
    • P.J. Neumann, J.T. Cohen, and M.C. Weinstein Updating cost-effectiveness - the curious resilience of the $50 000-per-QALY threshold N Engl J Med 371 2014 796 797
    • (2014) N Engl J Med , vol.371 , pp. 796-797
    • Neumann, P.J.1    Cohen, J.T.2    Weinstein, M.C.3
  • 43
    • 84934312224 scopus 로고    scopus 로고
    • Valuing reductions in fatal illness risks: Implications of recent research
    • Jun 30 [Epub ahead of print]
    • L.A. Robinson, and J.K. Hammitt Valuing reductions in fatal illness risks: implications of recent research Health Econ 2015 Jun 30 10.1002/hec.3214 [Epub ahead of print]
    • (2015) Health Econ
    • Robinson, L.A.1    Hammitt, J.K.2
  • 44
    • 33744810358 scopus 로고    scopus 로고
    • Comprehensive cost-utility analysis of newborn screening strategies
    • A.E. Carroll, and S.M. Downs Comprehensive cost-utility analysis of newborn screening strategies Pediatrics 117 2006 S287 S295
    • (2006) Pediatrics , vol.117 , pp. S287-S295
    • Carroll, A.E.1    Downs, S.M.2
  • 45
    • 60849136588 scopus 로고    scopus 로고
    • International perspectives on the cost-effectiveness of tandem mass spectrometry for rare metabolic conditions
    • R. Norman, M. Haas, and B. Wilcken International perspectives on the cost-effectiveness of tandem mass spectrometry for rare metabolic conditions Health Policy 89 2009 252 260
    • (2009) Health Policy , vol.89 , pp. 252-260
    • Norman, R.1    Haas, M.2    Wilcken, B.3
  • 46
    • 69549084264 scopus 로고    scopus 로고
    • Cost effectiveness as a criterion for newborn screening policy decisions
    • M.A. Baily, T.H. Murray, Johns Hopkins University Press Baltimore
    • S.D. Grosse Cost effectiveness as a criterion for newborn screening policy decisions M.A. Baily, T.H. Murray, Ethics and newborn genetic screening: new technologies, new challenges 2009 Johns Hopkins University Press Baltimore 58 88
    • (2009) Ethics and Newborn Genetic Screening: New Technologies, New Challenges , pp. 58-88
    • Grosse, S.D.1
  • 47
    • 76049100729 scopus 로고    scopus 로고
    • Economic evaluations of newborn screening interventions
    • W.J. Ungar, Oxford University Press New York
    • S.D. Grosse Economic evaluations of newborn screening interventions W.J. Ungar, Economic evaluation in child health 2009 Oxford University Press New York 113 132
    • (2009) Economic Evaluation in Child Health , pp. 113-132
    • Grosse, S.D.1
  • 48
    • 77953710259 scopus 로고    scopus 로고
    • QALY weights for neurosensory impairments in pediatric economic evaluations: Case studies and a critique
    • S.D. Grosse, L.A. Prosser, K. Asakawa, and D. Feeny QALY weights for neurosensory impairments in pediatric economic evaluations: case studies and a critique Expert Rev Pharmacoecon Outcomes Res 10 2010 293 308
    • (2010) Expert Rev Pharmacoecon Outcomes Res , vol.10 , pp. 293-308
    • Grosse, S.D.1    Prosser, L.A.2    Asakawa, K.3    Feeny, D.4
  • 49
    • 1242264767 scopus 로고    scopus 로고
    • Applying public health strategies to primary immunodeficiency diseases: A potential approach to genetic disorders
    • M.L. Lindegren, L. Kobrynski, S.A. Rasmussen, C.A. Moore, S.D. Grosse, M.L. Vanderford, and et al. Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders MMWR Recomm Rep 53 2004 1 29
    • (2004) MMWR Recomm Rep , vol.53 , pp. 1-29
    • Lindegren, M.L.1    Kobrynski, L.2    Rasmussen, S.A.3    Moore, C.A.4    Grosse, S.D.5    Vanderford, M.L.6
  • 50
    • 77953941716 scopus 로고    scopus 로고
    • Implementing routine testing for severe combined immunodeficiency within Wisconsin's newborn screening program
    • M.W. Baker, R.H. Laessig, M.L. Katcher, J.M. Routes, W.J. Grossman, J. Verbsky, and et al. Implementing routine testing for severe combined immunodeficiency within Wisconsin's newborn screening program Public Health Rep 125 Suppl 2 2010 88 95
    • (2010) Public Health Rep , vol.125 , pp. 88-95
    • Baker, M.W.1    Laessig, R.H.2    Katcher, M.L.3    Routes, J.M.4    Grossman, W.J.5    Verbsky, J.6
  • 51
    • 84938939005 scopus 로고    scopus 로고
    • Systematic neonatal screening for severe combined immunodeficiency and severe T-cell lymphopenia: Analysis of cost-effectiveness based on French real field data
    • M.C. Clement, N. Mahlaoui, C. Mignot, C. Le Bihan, H. Rabetrano, L. Hoang, and et al. Systematic neonatal screening for severe combined immunodeficiency and severe T-cell lymphopenia: analysis of cost-effectiveness based on French real field data J Allergy Clin Immunol 316 2015 1589 1593
    • (2015) J Allergy Clin Immunol , vol.316 , pp. 1589-1593
    • Clement, M.C.1    Mahlaoui, N.2    Mignot, C.3    Le Bihan, C.4    Rabetrano, H.5    Hoang, L.6
  • 52
    • 84948584003 scopus 로고    scopus 로고
    • The role of information provision in economic evaluations of newborn bloodspot screening: A systematic review
    • S.J. Wright, C. Jones, K. Payne, N. Dharni, and F. Ulph The role of information provision in economic evaluations of newborn bloodspot screening: a systematic review Appl Health Econ Health Policy 13 2015 615 626
    • (2015) Appl Health Econ Health Policy , vol.13 , pp. 615-626
    • Wright, S.J.1    Jones, C.2    Payne, K.3    Dharni, N.4    Ulph, F.5
  • 54
    • 59449101337 scopus 로고    scopus 로고
    • Prevention of rotavirus gastroenteritis among infants and children: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
    • M.M. Cortese, and U.D. Parashar Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep 58 2009 1 25
    • (2009) MMWR Recomm Rep , vol.58 , pp. 1-25
    • Cortese, M.M.1    Parashar, U.D.2
  • 55
    • 78049323353 scopus 로고    scopus 로고
    • State, federal efforts under way to identify children with "bubble boy syndrome."
    • B.M. Kuehn State, federal efforts under way to identify children with "bubble boy syndrome." JAMA 304 2010 1771 1773
    • (2010) JAMA , vol.304 , pp. 1771-1773
    • Kuehn, B.M.1
  • 57
    • 76049103409 scopus 로고    scopus 로고
    • Projected costs, risks, and benefits of expanded newborn screening for MCADD
    • L.A. Prosser, C.Y. Kong, D. Rusinak, and S.L. Waisbren Projected costs, risks, and benefits of expanded newborn screening for MCADD Pediatrics 125 2010 e286 e294
    • (2010) Pediatrics , vol.125 , pp. e286-e294
    • Prosser, L.A.1    Kong, C.Y.2    Rusinak, D.3    Waisbren, S.L.4
  • 58
    • 84892588228 scopus 로고    scopus 로고
    • Budget impact analysis-principles of good practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force
    • S.D. Sullivan, J.A. Mauskopf, F. Augustovski, J. Caro, K.M. Lee, M. Minchin, and et al. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force Value Health 17 2014 5 14
    • (2014) Value Health , vol.17 , pp. 5-14
    • Sullivan, S.D.1    Mauskopf, J.A.2    Augustovski, F.3    Caro, J.4    Lee, K.M.5    Minchin, M.6
  • 59
    • 84973427078 scopus 로고    scopus 로고
    • The use of economic evaluation to inform newborn screening policy decisions: The Washington State experience
    • In press
    • Grosse SD, Thompson JD, Ding Y, Glass M. The use of economic evaluation to inform newborn screening policy decisions: the Washington State experience. Milbank Q. (In press).
    • Milbank Q.
    • Grosse, S.D.1    Thompson, J.D.2    Ding, Y.3    Glass, M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.